Dev

INTERACTION BETWEEN ADENOSINE A2A RECEPTORS AND GROWTH FACTORS IN THE CONTROL OF NEURODEGENERATION AND BRAIN REPAIR Fellowships Portugal Neurodegenerative disease in general 2016    

CONTRIBUTION OF THE INTERPLAY BETWEEN PARAQUAT EXPOSURE, NOX1-DERIVED ROS AND A-SYNUCLEIN PATHOGENIC CHANGES, FOR THE DEVELOPMENT OF PARKINSON’S DISEASE: ARE EPIGENETIC MECHANISMS IMPLICATED? Fellowships Portugal Parkinson’s disease & PD-related disorders 2016    

COMBINING TRANSPLANTATION OF NEURAL STEM CELLS AND MUTANT ATAXIN-3 GENE SILENCING AS A NEW THERAPEUTIC STRATEGY FOR MACHADO-JOSEPH DISEASE Fellowships Portugal Spinocerebellar ataxia (SCA) 2016    

Dissecting the role of alpha-synuclein phosphorylation in Parkinson’s disease Fellowships Portugal Parkinson’s disease & PD-related disorders 2016    

ANÁLISE DA PREDISPOSIÇÃO DA POPULAÇÃO PARA DOENÇAS NEURODEGENERATIVAS COM BASE NA AVALIAÇÃO DO POTENCIAL TOXICOLÓGICO DE SOLOS, ÁGUAS E VEGETAIS NA ENVOLVENTE DE DUAS MINAS DE MN.ANALYSIS OF PREDISPOSITION OF THE POPULATION FOR NEURODEGENERATIVE DISEASES BASED ON THE EVALUATION OF…

PEPTIDOMIMETIC BACE-1 INHIBITOR PRODRUGS FOR ALZHEIMER’S DISEASE: THE POTENTIAL OF GLUCOSYLATION TO CIRCUMVENT THE BLOOD-BRAIN BARRIER Fellowships Portugal Alzheimer’s disease & other dementias 2016    

Targeting necroptosis in Alzheimer’s disease: a shift from neuroinflammation to neuroprotection Fellowships Portugal Alzheimer’s disease & other dementias 2016    

DECIPHERING THE MECHANISMS UNDERLYING THE LOST OF BDNF NEUROPROTECTION IN ALZHEIMER’S DISEASE Fellowships Portugal Alzheimer’s disease & other dementias 2016    

CALPAIN-MEDIATED PROTEOLYSIS IN MACHADO-JOSEPH DISEASE: BIOMARKER AND THERAPEUTIC TARGET Fellowships Portugal Spinocerebellar ataxia (SCA) 2016    

TARGETING NATURAL ANTIOXIDANTS TO MITOCHONDRIA: A NEW THERAPEUTIC APPROACH ON NEURODEGENERATIVE DISEASES Fellowships Portugal Neurodegenerative disease in general 2016